DETERMINATION OF IN VITRO OUTLET OF ”AMRADIPIN” 4/5 MG TABLETES (GM PHARMACEUTICALS) AND ITS ANALOGUE ”AMLESSA” 4/5 MG TABLETES (KRKA) USING METHOD OF HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

Authors

  • Chikviladze T. ჩიკვილაძე თ.
  • Lashauri N. ლაშაური ნ.
  • Chincharadze D. ჭინჭარაძე დ.
  • Jorjikia M. ჯორჯიკია მ.
  • Otarashvili T. ოთარაშვილი თ.

DOI:

https://doi.org/10.52340/csw.2017.51..117-119

Abstract

 Arterial hypertension is a major risk factor for the development of vascular diseases of the heart, brain and kidneys for both sexes, different ages and racial groups. According to numerous data, 70% of people with arterial hypertension require combined treatment. One of the most successful combination is a combination of angiotensin-converting enzyme inhibitor - Perindopril and calcium antagonist – Amlodipine . Purpose of investigation was – determination of in vitro outlet of ”amradipin” 4/5 mg tablets produced by the Georgian pharmaceutical company “GMP” and its analogue “amlessa” 4/5 mg tablets produced by the Krka (Slovenia). According to the received results average percent quantity outlet of amlodipine besylate from amradipine is 92,99%, %, from amlessa - 95,49%, inclination in comparison with analogue is -2.62% ( norm ± 5%).2,5 %, average percent quantity outlet of perindopril erbumine from amradipine is 94,26%%, from amlessa - 97,90%, inclination in comparison with analogue is -3.72% ( norm ± 5%).2,5 %. ” amradipin” 4/5 mg tablets containing amlodipine besylate and perindopril erbumine, produced by the Georgian pharmaceutical company ”GMP” are characterized by good outlet quality.  

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

1. წინამძღვრიშვილი ბ., ყურაშვილი ლ., ტრაპაიძე დ. არტერიული ჰიპერტენზია (გაიდლაინი) საქარ- თველოს ჰიპერტენზიის შემსწავლელი საზოგადოება, საქართველოს კარდიოლოგთა კოლეჯი და ჯანმრთელობის სერვისის კვლევის ცენტრი, 2006წ.
2. Государственная Фармакопея Российской Федерации. XII 2007 .ст 552-553
3. Григорьев Ю.В. Рациональная антигипер- тензивная терапия / / ГВМУ МО РФ, ГИУВ МО РФ: Методические рекомендации. - М., 2000.
4. British Pharmakopoeia. 2013. p2761-2765
5. United States Pharmacopeia 2015

Downloads

Published

2019-01-17

How to Cite

ჩიკვილაძე თ. C. T., ლაშაური ნ. L. N., ჭინჭარაძე დ. C. D., ჯორჯიკია მ. J. M., & ოთარაშვილი თ. O. T. (2019). DETERMINATION OF IN VITRO OUTLET OF ”AMRADIPIN” 4/5 MG TABLETES (GM PHARMACEUTICALS) AND ITS ANALOGUE ”AMLESSA” 4/5 MG TABLETES (KRKA) USING METHOD OF HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. COLLECTION OF SCIENTIFIC WORKS OF TBILISI STATE MEDICAL UNIVERSITY, 51, 117–119. https://doi.org/10.52340/csw.2017.51.117-119

Most read articles by the same author(s)